No abstract available
MeSH terms
-
Angiogenesis Inhibitors / pharmacology*
-
Angiogenesis Inhibitors / therapeutic use
-
Animals
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal, Humanized
-
Benzenesulfonates / pharmacology
-
Bevacizumab
-
Biomarkers, Tumor / metabolism*
-
Cytokines / metabolism*
-
Disease-Free Survival
-
Endothelial Cells* / drug effects
-
Humans
-
Indoles / pharmacology
-
Neoplasms / blood supply
-
Neoplasms / drug therapy*
-
Neoplasms / metabolism*
-
Neoplasms / mortality
-
Neoplasms / pathology
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Pyridines / pharmacology
-
Pyrroles / pharmacology
-
Sorafenib
-
Sunitinib
-
Survival Analysis
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Benzenesulfonates
-
Biomarkers, Tumor
-
Cytokines
-
Indoles
-
Phenylurea Compounds
-
Pyridines
-
Pyrroles
-
Vascular Endothelial Growth Factor A
-
Niacinamide
-
Bevacizumab
-
Sorafenib
-
Sunitinib